STK11IP: A Potential Drug Target for Cancer and Other Diseases

Target Name: STK11IP

NCBI ID: G114790

STK11IP: A Potential Drug Target for Cancer and Other Diseases

STK11IP (Serine/threonine kinase 11 interacting protein) is a protein that is expressed in various tissues and cells throughout the body. It is a key regulator of cell signaling pathways, and its interaction with other proteins has been identified as a potential drug target or biomarker.

The STK11IP protein is a member of the STK11 family of serine/threonine kinases, which are known for their role in cell signaling pathways. These kinases are involved in the regulation of a wide range of cellular processes, including cell growth, differentiation, and survival . The STK11IP protein is specifically involved in the regulation of cell signaling pathways related to the development and maintenance of tissues and organs, as well as the regulation of cell cycle progression.

One of the key functions of the STK11IP protein is its role in the regulation of the G1/S transition, which is a critical step in the cell cycle that involves the progression of cells from the G1 phase to the S phase. During the G1/ S transition, cells prepare for cell division by producing more organelles and increasing their size. The STK11IP protein is involved in the regulation of the G1/S transition by promoting the transition from G1 to S phase and inhibiting the transition from S to G2 phase.

Another function of the STK11IP protein is its role in the regulation of cell signaling pathways related to cell survival and angiogenesis. These signaling pathways are involved in the regulation of cell growth, angiogenesis, and the regulation of cell survival. The STK11IP protein is involved in These signaling pathways regulate the activity of several transcription factors, including nuclear factor kappa B (NF-kappa-B), transcription factor-DNA binding protein (TBP), and long non-coding RNA (LNRNA).

The STK11IP protein has also been identified as a potential drug target or biomarker due to its involvement in several diseases, including cancer, neurodegenerative diseases, and developmental disorders. For example, studies have shown that the expression of the STK11IP protein is increased in various types of cancer, including breast cancer, lung cancer, and colon cancer. Additionally, the STK11IP protein has been shown to be involved in the regulation of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.

Furthermore, the STK11IP protein has also been shown to be involved in the regulation of developmental disorders, such as Down syndrome and Fragile X syndrome. These conditions are characterized by the presence of specific genetic mutations that result in the development of abnormal cellular structures or the disruption of specific signaling pathways.

In conclusion, the STK11IP protein is a key regulator of cell signaling pathways and has been identified as a potential drug target or biomarker for several diseases. Further research is needed to fully understand the role of the STK11IP protein in these diseases and to develop effective treatments .

Protein Name: Serine/threonine Kinase 11 Interacting Protein

Functions: May regulate STK11/LKB1 function by controlling its subcellular localization

More Common Targets